Full-Service Clinical Development Built Around Biotech Innovation
Integrated clinical development rewards multidisciplinary scientific expertise, collaborative partnership and scalable delivery that evolves alongside program requirements. Consistent program continuity across Medical Affairs, Clinical Operations, Regulatory Affairs, Data Management and Pharmacovigilance supports confident program delivery at every stage.
Evestia Clinical works as an integrated scientific partner throughout clinical development. Sponsors gain senior experts working directly alongside their teams, flexible delivery models and globally capable program management, through our Full-Service CRO model or specialist embedded resource via FSP Solutions, scaling from early Phase I through global registration.
One Integrated Team
All disciplines working within a single program governance framework, eliminating the coordination burden of managing multiple specialist vendors.
Senior Expert Access
Senior scientific and operational leaders engaged throughout program delivery, not just at project initiation. Faster decisions, greater confidence at every milestone.
Flexible Delivery Models
Full-Service CRO and FSP Solutions providing scalable expertise aligned with program requirements, adapting throughout program evolution.
Globally Capable
Established international site networks, regional regulatory expertise and multinational operational capability, delivered with boutique responsiveness.
Full-Service Clinical Development Expertise
Evestia Clinical provides Phase I–IV & Post-Marketing clinical development support through 12+ integrated service areas, combining specialist therapeutic expertise in oncology, rare disease and advanced therapies with the operational leadership and flexibility needed to deliver successful clinical outcomes.
Phase I–IV
Clinical Development Support
First-in-human to post-marketing
12+
Integrated Service Areas
Breadth of full-service capability
300+
Oncology Studies Supported
Across all phases and modalities
120+
Rare Disease Studies Supported
Including orphan drug programs
Full-Service Clinical Development Support Across Every Stage of Drug Development
Clinical development brings together scientific, operational and regulatory priorities that evolve at every milestone. Integrated delivery keeps these disciplines aligned and supports confident program progression throughout, from first-in-human studies through global registration.
Evestia Clinical's integrated Full-Service CRO model simplifies that complexity. As a specialist Biotech CRO, all clinical development functions operate within one coordinated team, aligned to sponsor objectives and governed through a single program framework across Phase I, Phase II and Phase III.
Sponsors across oncology, rare disease, neurology, immunology, inflammation and cell and gene therapy gain one accountable development partner that combines therapeutic depth, global operational capability and the scientific collaboration needed to strengthen program delivery and advance programs with greater operational consistency.
What Is a Full-Service CRO?
A Full-Service CRO gives sponsors one accountable clinical development partner responsible for integrating all functions, maintaining program quality and driving consistent outcomes from study planning through regulatory submission.
Rather than managing separate vendor relationships for monitoring, data management, regulatory affairs, biostatistics and pharmacovigilance, sponsors access all of these disciplines through a single integrated team. The result is better communication, greater operational consistency across every study deliverable and more efficient decision-making at every milestone.
The service areas integrated within Evestia Clinical's Full-Service CRO model include:
Why Sponsors Choose a Full-Service CRO
Working with a Full-Service CRO creates one accountable clinical development partner responsible for program quality, timeline protection and regulatory outcomes across every study function.
For biotechnology companies managing portfolio growth, the right partnership model supports confident program progression and keeps development advancing at every stage.
One Accountable Partner
Working with a Full-Service CRO is not simply about consolidating vendors. It creates one accountable clinical development partner responsible for maintaining program quality, protecting timelines and supporting successful regulatory outcomes.
Integrated Expertise
Specialist disciplines work collaboratively from study planning through close-out. Regulatory strategy, data management, biostatistics and clinical operations operate within a single governance framework, reducing the gaps that arise when functions are managed separately.
Consistent Quality Across Every Function
Standardized processes, shared oversight and integrated quality management help maintain compliance and scientific rigor throughout program delivery, from first-in-human studies to pivotal registration trials.
Coordinated Program Leadership
A single integrated team communicates more efficiently than a network of independent vendors. Issues are identified and resolved more effectively, supporting confident program progression and operational clarity at every milestone.
Embedded Scientific Partnership
A Full-Service CRO works as an integrated scientific partner throughout development, combining operational execution with strategic scientific input. Sponsors retain focus on their science while a collaborative, aligned team drives program delivery.
Full-Service Clinical Development Solutions
Every service below operates within one integrated team, aligned to the same program outcome. Integrated delivery keeps communication direct, decisions fast and accountability clear across every clinical development discipline.
Clinical Operations
End-to-end oversight of study execution, coordinating all operational activities to ensure studies are delivered on time, within budget and to the highest quality standards.
- Operational planning
- Study oversight
- Cross-functional coordination
- Issue management
- Quality oversight
- Stakeholder communication
Clinical Trial Management
Strong program leadership and proactive oversight coordinating study activities, managing timelines, overseeing vendors and maintaining alignment between sponsors, investigators and stakeholders.
- Project management
- Timeline development
- Risk management
- Budget oversight
- Vendor coordination
- Governance and reporting
Clinical Monitoring
Specialist monitoring teams maintaining study quality and patient safety across every investigator site, with risk-based and remote monitoring approaches integrated throughout.
- Site initiation visits
- Routine monitoring
- Risk-based monitoring
- Site management
- Protocol compliance oversight
- Close-out activities
Clinical Site Management
Ongoing site support optimizing investigator performance, improving recruitment and maintaining study quality throughout program delivery.
- Site onboarding
- Recruitment support
- Training delivery
- Communication management
- Issue resolution
- Performance oversight
Clinical Data Management
Reliable, submission-ready clinical data supporting informed decision-making and regulatory confidence throughout development.
- Database design
- Data validation
- Data cleaning
- Query management
- Database lock activities
Study Start-Up
Accelerating site activation and protecting first-patient-in timelines through proactive regulatory coordination, site selection and investigator engagement.
- Site feasibility assessments
- Site selection
- Investigator engagement
- Ethics submissions
- Regulatory coordination
- Study activation planning
Regulatory Affairs
Regulatory strategy, submission planning and authority interactions managed as an integrated part of the broader clinical development program.
- Regulatory strategy
- Submission planning
- Authority interactions
- Regulatory documentation
- Global regulatory compliance
Biostatistics
Statistical planning and analysis supporting robust endpoint design, regulatory confidence and informed commercial decision-making across all phases.
- Statistical analysis plans
- Sample size calculations
- Interim analyzes
- Final study analyzes
- Regulatory reporting support
Medical Writing
High-quality clinical documentation supporting both study execution and regulatory submissions, prepared by experienced scientific writers.
- Protocols
- Investigator brochures
- Clinical study reports
- Regulatory submissions
- Patient materials
Pharmacovigilance
Comprehensive safety monitoring and pharmacovigilance support maintaining patient safety and regulatory compliance throughout clinical development.
- Safety monitoring
- Adverse event reporting
- Signal detection
- Safety database support
- Regulatory compliance
Functional Service Provider (FSP) Solutions
Dedicated embedded specialists integrated within sponsor teams, providing scalable expertise aligned with program requirements and sponsor governance structures.
- Embedded clinical teams
- Flexible resourcing
- Sponsor-integrated delivery
- Specialist functional support
- Scalable engagement models
Pharmacokinetics
PK/PD expertise supporting drug development decision-making, regulatory submissions and biologics immunogenicity assessments across all development phases.
- PK study design
- Sample collection planning
- PK/PD modeling
- Regulatory reporting
- Bioanalytical coordination
How Evestia Strengthens Clinical Development
Integrated support keeps scientific, operational and regulatory disciplines aligned, supporting program continuity, coordinated delivery and scientific leadership throughout every phase of development.
One Integrated Partner
All clinical development disciplines operate within a single coordinated team, providing one point of accountability across every study function and supporting program continuity through consistent governance and integrated quality management.
Resource That Scales With Your Portfolio
Clinical development capability available immediately through Full-Service CRO and FSP delivery models, enabling biotechnology companies to scale rapidly with scalable expertise aligned with program needs.
Coordinated Multinational Delivery
Integrated operational leadership, with central oversight and local expertise, protects quality and timelines across international programs spanning multiple regulatory jurisdictions and site networks.
Disease-Specific Scientific Depth
Therapeutic depth across oncology, rare disease, cell and gene therapy and advanced therapies strengthens study design, site selection, endpoint strategy and regulatory confidence throughout every program.
Operational Bandwidth
Experienced specialists, embedded through Full-Service CRO and FSP models, provide the operational bandwidth and scientific expertise programs demand through embedded specialist expertise aligned with program growth.
Program Momentum
Senior-led delivery, integrated governance and coordinated decision-making keep programs advancing, supporting confident program progression at every stage of the development lifecycle.
Why Biotech Companies Choose Evestia Clinical
Biotechnology innovation advances through integrated scientific partnership, scalable expertise and long-term collaborative delivery that evolves with each program. As portfolios mature and programs progress, integrated clinical development capability supports confident program execution at every stage.
Evestia Clinical integrates within existing governance structures from early Phase I through global Phase III registration, adapting to portfolio priorities through program growth. Sponsors requiring embedded resource in specific functions access targeted support through our FSP Solutions model. As a dedicated Biotech CRO, we understand the priorities of biotechnology development.
Integrated Expertise Without Internal Overhead
Immediate access to experienced clinical development professionals across all functional areas, from Medical Affairs, Clinical Operations and Regulatory Affairs to Data Management and Pharmacovigilance, through scalable embedded expertise rather than internal build.
Integrated Operational Support
All study activities coordinated through a single accountable partner, providing consistent governance and clear communication across every clinical development discipline.
Flexible Delivery Models
Full-Service CRO and FSP Solutions that align with internal structures, governance requirements and program objectives at every stage, adapting rapidly as program priorities and requirements evolve.
Therapeutic Depth Across Complex Areas
Genuine expertise across oncology, rare disease, neurology, immunology, inflammation and cell and gene therapy, ensuring program strategies are informed by relevant scientific and operational knowledge throughout every study.
Therapeutic Expertise
Successful clinical development requires both operational excellence and deep therapeutic understanding. Disease-specific knowledge directly improves study design, site selection, endpoint strategy, patient recruitment and regulatory positioning, strengthening outcomes across complex therapeutic programs.
Oncology
Supporting sponsors developing innovative therapies across solid tumors, hematological malignancies, immuno-oncology and precision medicine.
Learn moreRare Disease
Helping sponsors advance programs requiring specialist recruitment, operational and regulatory expertise in orphan drug development.
Learn moreNeurology
Supporting programs across Alzheimer's disease, Parkinson's disease, ALS, epilepsy and other neurological disorders.
Learn moreInflammation
Supporting programs across inflammatory conditions and emerging therapeutic approaches.
Learn moreCell & Gene Therapy
Supporting sponsors developing advanced therapies including cell therapies, gene therapies and ATMPs across complex regulatory and operational landscapes.
Learn moreOrphan Drug Development
Supporting sponsors developing therapies for rare and ultra-rare diseases through orphan designation strategy, regulatory planning, regulatory incentive programs and specialized clinical development expertise. Our Rare Disease CRO and Regulatory Affairs capabilities work together to support sponsors pursuing orphan designation across the FDA, EMA and other global health authorities, including those developing Cell & Gene Therapy products for rare indications.
Learn More About Orphan Drug DevelopmentSupporting Every Phase of Clinical Development
Program priorities evolve at every stage of development. First-in-human studies demand intensive safety oversight and biomarker planning that shapes everything downstream. Proof-of-concept programs require endpoint precision and regulatory foresight. Pivotal registration studies need large-scale operational coordination and multinational submission expertise. Evestia Clinical adapts support, governance and scientific input as programs mature, maintaining continuity and momentum across the entire development lifecycle.
Phase I Clinical Trials
First-in-human studies demand intensive safety oversight, site selection and biomarker planning that shapes every downstream development decision. The scientific and operational foundations established in Phase I help establish strong program foundations throughout.
Learn morePhase II Clinical Trials
Proof-of-concept studies require biomarker-driven patient stratification, adaptive design options and exposure-response analyzes. The evidence generated helps shape regulatory strategy, commercial positioning and the case for continued investment.
Learn morePhase III Clinical Trials
Pivotal registration programs require large-scale site coordination, multinational regulatory submissions and robust safety datasets. Operational consistency across every study location directly determines submission quality and approval timelines.
Learn morePost-Marketing Studies
Long-term safety and effectiveness monitoring following approval, maintaining regulatory compliance and generating the real-world evidence that supports commercial success and lifecycle management.
Global Clinical Trial Delivery
Effective global delivery depends on regional expertise, investigator networks and integrated program leadership, bringing together regional regulatory knowledge, local operational teams and central program oversight to maintain consistent quality across every participating country simultaneously.
As a Global CRO, Evestia Clinical coordinates Clinical Operations, Regulatory Affairs and study oversight across multiple regions, combining regional expertise and local investigator relationships with central program oversight to deliver consistent quality across international studies. Our capabilities span:
- Study start-up
- Site selection
- Investigator engagement
- Patient recruitment
- Monitoring
- Data oversight
- Regulatory coordination
- Study close-out
Why Evestia Clinical?
The CRO a sponsor chooses shapes the scientific quality of every development decision and the strength of every regulatory submission. Choosing Evestia Clinical means combining therapeutic depth with global operational capability, all delivered with the senior access and collaborative responsiveness that complex programs demand.
- Specialist therapeutic expertise
- Senior-led program delivery
- Flexible operating models
- Global study capabilities
- Regulatory knowledge
- Collaborative partnership
Why Evestia Clinical Delivers More
Choosing the right Full-Service CRO is one of the most important strategic decisions in a clinical program. Sponsors who choose Evestia Clinical gain a partner committed to program outcomes, not just contract deliverables.
Integrated Expertise Across Every Discipline
Integrated expertise across all clinical development disciplines, operating within a single governance framework, strengthens program quality and keeps every function aligned to the same outcomes.
Senior Experts Who Stay Involved
Senior scientific and operational leaders remain actively engaged throughout program delivery. Sponsors gain faster decisions, clearer communication and greater confidence at every milestone.
Flexible Partnerships That Scale With Your Program
Full-Service CRO and FSP delivery models that adapt to program evolution and portfolio requirements. Sponsors scale clinical development capability with scalable capability aligned with program requirements, maintaining operational agility at every stage.
Integrated Delivery Through One Team
All clinical development disciplines, from Medical Affairs, Clinical Operations and Regulatory Affairs through Biostatistics, Pharmacovigilance and Medical Writing, coordinated through a single integrated team. Sponsors gain the simplicity of one partner with the capability of many specialists.
Scientific Expertise Across Complex Therapeutic Areas
Specialist experience across oncology, rare disease, neurology, immunology, inflammation and cell and gene therapy. Therapeutic depth informs better study design, stronger endpoint strategies and more confident regulatory positioning throughout every program.
Global Capability With Senior Access
Multinational operational capability, established investigator networks and regional regulatory expertise, delivered with the responsiveness and senior access that complex programs demand.
Frequently Asked Questions
Further Reading
Explore our guides to help you navigate CRO selection and clinical trial outsourcing.
Clinical Development Built Around Your Program
Integrated clinical development, therapeutic knowledge and flexible Full-Service and FSP delivery give sponsors a single, accountable partner to strengthen program delivery and support confident program progression.
Whether you require support for a single study or a complex global program, Evestia Clinical provides the integrated partnership, scientific expertise and collaborative delivery your program requires.